Dermal Fillers

At Dermatology Associates of the Tri-Cities, we are proud to provide a wide selection of dermal fillers to give our patients many options for reducing fine lines, adding lift, and achieving smoother, younger looking skin.

The dermal fillers we offer include:

The Allergan Juvederm® collection of dermal fillers including Voluma®. We also offer Restylane®.

To get more personalized information about dermal fillers, schedule a complimentary consultation with us at any of our three Cosmetic Centers. An initial consultation and assessment is required for new filler patients. — Call (423) 246-4961 or (800) 445-7274 option 15 for Kingsport, (423) 764-7131 option 6 for Bristol, or (423) 928-9014 option 3 for the Johnson City office.

JUVEDERM®

Juvederm® is a smooth consistency gel that helps to add volume and hydration to your skin. Juvederm® instantly restores your skin's volume and smoothes away facial wrinkles and folds, like the “smile lines” or “parentheses” (nasolabial folds—the creases that run from the bottom of your nose to the corners of your mouth). Results can last up to 1 year.

VOLUMA®

Over time, the cheeks flatten, and the skin may begin to sag. This is caused by a natural loss of volume in the cheek area, or what the experts call age-related midface volume loss. Juvederm Voluma® XC is designed to add volume beneath the skin’s surface to lift and contour the cheek area. Juvederm Voluma® XC adds volume to correct age-related volume loss in the cheeks to help create a more youthful appearance.

For more information about the Juvéderm® family of products, click here.

RESTYLANE®

Restylane® is a safe and natural cosmetic dermal filler that restores volume and fullness to the skin to correct moderate to severe facial wrinkles and folds, such as nasolabial folds. It also works well for lip augmentation. Results last for about 6 months.

For more information about Restylane®, click here.

• Healthcare professionals are encouraged to discuss the potential risks of soft-­tissue injections with their patients prior to treatment and ensure that patients are aware of signs and symptoms of potential  complications
• The safety and effectiveness for the treatment of anatomic regions other than moderate to severe facial wrinkles and folds with JUVÉDERM® Ultra XC and JUVÉDERM® Ultra Plus XC, the lips and perioral area for lip augmentation with JUVÉDERM® Ultra XC, the mid-­face with JUVÉDERM VOLUMA® XC, and the lips and perioral area for lip augmentation and correction of perioral rhytids with JUVÉDERM VOLBELLA® XC have not been established in controlled clinical studies
• As with all transcutaneous procedures, dermal filler implantation carries a risk of infection. Follow standard precautions associated with injectable materials
• The safety for use during pregnancy, in breastfeeding females, and in patients with known susceptibility to keloid formation, hypertrophic scarring, and pigmentation disorders has not been studied
• The safety for use of JUVÉDERM® Ultra XC and JUVÉDERM® Ultra Plus XC in patients under 18 years, JUVÉDERM VOLUMA® XC in patients under 35 or over 65 years, and JUVÉDERM VOLBELLA® XC in patients under 22 years has not been established

Use with caution in patients on immunosuppressive therapy

• Patients who are using products that can prolong bleeding (such as aspirin, nonsteroidal anti-­inflammatory drugs, and warfarin) may experience increased bruising or bleeding at treatment sites
• If laser treatment, chemical peel, or any other procedure based on active dermal response is considered after treatment, or if the product is administered before the skin has healed completely, there is a possible risk of an inflammatory reaction at the treatment site
• Patients who experience skin injury near the site of implantation may be at a higher risk for adverse events
• The safety of JUVÉDERM VOLUMA® XC injectable gel for use in patients with very thin skin in the mid-­?face has not been established
• Patients may experience late onset nodules with use of dermal fillers, including JUVÉDERM VOLUMA® XC
• Patients may experience late onset adverse events with use of dermal fillers, including JUVÉDERM VOLBELLA® XC

ADVERSE EVENTS

The most commonly reported side effects for JUVÉDERM® injectable gels were temporary injection-­-site redness, swelling, pain/tenderness, firmness, lumps/bumps, bruising, discoloration, and itching. For JUVÉDERM VOLBELLA® XC, dryness was also reported. For JUVÉDERM® Ultra XC or JUVÉDERM® Ultra Plus XC, side effects were mostly mild or moderate in severity, with a duration of 14 days or less; for JUVÉDERM VOLUMA® XC, they were predominantly moderate in severity, with a duration of 2 to 4 weeks; and for JUVÉDERM VOLBELLA® XC, they were predominantly mild or moderate, with a duration of 30 days or less.

To report an adverse reaction with JUVÉDERM® Ultra XC, JUVÉDERM® Ultra Plus XC, JUVÉDERM VOLUMA® XC, or JUVÉDERM VOLBELLA® XC, please call Allergan at 1-­800-­433-­8871. Please also visit JuvedermDFU.com for more information.

JUVÉDERM® Ultra XC, JUVÉDERM® Ultra Plus XC, JUVÉDERM VOLUMA® XC, and JUVÉDERM VOLBELLA® XC injectable gels are available by prescription only.